Metabolomic Analyses to Identify Candidate Biomarkers of Cystinosis.
Ontology highlight
ABSTRACT: Cystinosis is a rare, devastating hereditary disease secondary to recessive CTNS gene mutations. The most commonly used diagnostic method is confirmation of an elevated leukocyte cystine level; however, this method is expensive and difficult to perform. This study aimed to identify candidate biomarkers for the diagnosis and follow-up of cystinosis based on multiomics studies. The study included three groups: newly-diagnosed cystinosis patients (patient group, n = 14); cystinosis patients under treatment (treatment group, n = 19); and healthy controls (control group, n = 30). Plasma metabolomics analysis identified 10 metabolites as candidate biomarkers that differed between the patient and control groups [L-serine, taurine, lyxose, 4-trimethylammoniobutanoic acid, orotic acid, gluta
SUBMITTER: Nemutlu E
PROVIDER: S-EPMC9916752 | biostudies-literature | 2023 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA